Lazard Asset Management’s Evolent Health EVH Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$250K	Sell	109,623 -239,799	-69%	-$761K	﹤0.01%	1565
2025 Q4	$1.4M	Sell	349,422 -395,469	-53%	-$2.2M	﹤0.01%	1041
2025 Q3	$6.3M	Buy	744,891 +106,534	+17%	+$1.03M	0.01%	520
2025 Q2	$7.19M	Buy	638,357 +39,516	+7%	+$363K	0.01%	630
2025 Q1	$5.67M	Sell	598,841 -45,956	-7%	-$464K	0.01%	648
2024 Q4	$7.25M	Sell	644,797 -1,726,255	-73%	-$30.3M	0.01%	544
2024 Q3	$67.1M	Buy	2,371,052 +2,007,004	+551%	+$51.7M	0.09%	164
2024 Q2	$6.96M	Buy	364,048 +80,590	+28%	+$2.06M	0.01%	597
2024 Q1	$9.29M	Buy	283,458 +174,826	+161%	+$5.58M	0.01%	553
2023 Q4	$3.59M	Buy	+108,632	New	+$3.07M	﹤0.01%	746
2020 Q1	–	Sell	-3,140	Closed	-$28K	–	1620
2019 Q4	$28K	Buy	3,140 +2,775	+760%	+$22.5K	﹤0.01%	1167
2019 Q3	$2K	Sell	365 -335	-48%	-$2.4K	﹤0.01%	1397
2019 Q2	$5K	Hold	700	–	–	﹤0.01%	1169
2019 Q1	$8K	Sell	700 -238,500	-100%	-$3.78M	﹤0.01%	1102
2018 Q4	$4.77M	Sell	239,200 -24,380	-9%	-$564K	0.01%	544
2018 Q3	$7.49M	Buy	263,580 +4,455	+2%	+$106K	0.01%	499
2018 Q2	$5.45M	Sell	259,125 -348,780	-57%	-$6.6M	0.01%	546
2018 Q1	$8.66M	Buy	+607,905	New	+$8.7M	0.01%	461